These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
    Author: Koh YS, Chang K, Kim PJ, Seung KB, Baek SH, Shin WS, Lim SH, Kim JH, Choi KB.
    Journal: Int J Cardiol; 2008 Jul 21; 127(3):430-2. PubMed ID: 17698228.
    Abstract:
    OBJECTIVE: This study investigated whether the single nucleotide polymorphism (SNP) in the matrix metalloproteinase-9 (MMP-9) promoter (-1562C>T) is a significant risk factor for an acute myocardial infarction (AMI) and if SNPs affect the transcription of the gene that elevates the MMP-9 expression level. METHODS: A polymerase chain reaction, followed by a restriction fragment length polymorphism analysis, was performed in 173 control participants and 206 AMI patients. The serum levels of MMP-9 in the groups with or without the SNP were measured using ELISA and compared. RESULTS: There was a significantly higher incidence of th-1562C>T MMP-9 polymorphism in the AMI patients compared to the control group (27.6% vs 17.9%, p=0.04). A multiple logistic regression analysis of the risk factors for coronary artery disease and the MMP-9 polymorphism showed the MMP-9 polymorphism to be an important factor in the prediction of an AMI (odds ratio 1.67, 95% confidence interval 1.02-2.67, p=0.04). The serum level of MMP-9 was also higher in the group with the SNP than in the group without (494.8+/-3.66 ng/ml vs 309.5+/-2.19 ng/ml, p=0.04). CONCLUSION: These results suggest that the -1562C>T polymorphism in the MMP-9 promoter is strongly associated with an AMI.
    [Abstract] [Full Text] [Related] [New Search]